newsfilter
← Latest News
GlobeNewswire·

Ocugen to Participate in Upcoming November Investor and Industry Conferences

MALVERN, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ:OCGN), a pioneering biotechnology company developing gene therapies for blindness diseases, today announced that the Company